Description
Product Overview In endocrine research, controlling the duration of receptor activation is critical. CJC-1295 (No DAC) represents a highly refined version of the shortest fully functional GHRH fragment (amino acids 1-29). By omitting the Drug Affinity Complex (DAC), this peptide avoids continuous receptor activation, preventing pituitary receptor downregulation.
Mechanism of Action
-
Pituitary Stimulation: It acts directly on the anterior pituitary gland to stimulate the secretion of endogenous growth hormone.
-
Pulsatile Kinetics: With a physiological half-life of approximately 30 minutes, it is ideal for studies requiring a simulated “pulse” rather than a sustained baseline elevation.
-
Synergistic Models: Often researched in conjunction with GHRPs (like Ipamorelin) to study the amplification of the hormonal pulse.
Quality Assurance
-
Identity: Modified GRF 1-29 (Tetrasubstituted)
-
Purity: >99% Verified by HPLC
-
Form: Sterile White Lyophilized Powder
Disclaimer:
WARNING – FOR RESEARCH USE ONLY: This product is sold exclusively as an analytical reference standard and research chemical. It is NOT an FDA-approved drug or medical device. Not for human consumption, therapeutic use, or veterinary application. Any reference to physiological effects is strictly for educational context.
